Contract Manufacturing Stocks Scatter Chart

22 companies Industry in Healthcare P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 22 Contract Manufacturing stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 2.9% and the median P/E 24.62. Pinned to the edge: 1 outliers on X and 2 on Y.

Rank correlation -0.20 Trend R² 0.00 X middle half 0.9% to 9.8% Y middle half 14.52 to 39.79
5High Revenue Growth (1y) (TTM), high P/E
6Low Revenue Growth (1y) (TTM), high P/E
5Low Revenue Growth (1y) (TTM), low P/E
6High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

22 plotted
# Industry
1 TMOThermo Fisher Scientific 8.3% 36.63 $259.44B Life Sciences Tools
2 PFEPfizer 1.3% 40.85 $164.73B Pharmaceuticals
3 TEVATeva Pharmaceutical Industries 2.7% 102.64 $51.97B Generic Drugs
4 ZTSZoetis 0.9% 13.76 $34.16B Animal Health
5 WSTWest Pharmaceutical Services 12.6% 45.92 $29.09B Medical Supplies
6 STESteris 8.1% 31.11 $25.67B Medical Devices
7 IFFInternational Flavors & Fragrances 24.3% 36.61 $20.32B Specialty Chemicals
8 CRLCharles River Laboratories International -1.2% 402.10OUT $16.18B Contract Research
9 RDYDr Reddys Laboratories -10.5% 33.78 $12.31B Generic Drugs
10 PODDInsulet 26.5% 24.66 $10.58B Medical Devices
11 LNTHLantheus Holdings 2.4% 24.58 $6.64B Diagnostic Equipment
12 LGNDLigand Pharmaceuticals 1.0% 119.78OUT $6.18B Biotechnology
13 OGNOrganon -3.2% 17.14 $3.65B Pharmaceuticals
14 ADMAAdma Biologics 6.3% 16.78 $3.05B Biotechnology
15 AMPHAmphastar Pharmaceuticals 3.1% 12.64 $1.25B Generic Drugs
16 IARTIntegra Lifesciences Holdings 0.8% 85.64 $1.12B Medical Devices
17 MGTXMeiraGTx Holdings 1,366%OUT 11.36 $896.15M Gene and Cell Therapy
18 EMBCEmbecta -7.6% 4.32 $366.02M Medical Devices
19 ELTPElite Pharmaceuticals 17.8% 5.90 $355.46M Generic Drugs
20 UTMDUtah Medical Products -9.6% 22.09 $228.50M Medical Devices
21 NSYSNortech Systems 9.0% 16.97 $30.89M Industrial Machinery
22 PLURPluri 10.0% 0.00 $15.09M Gene and Cell Therapy

Frequently Asked Questions

Which Contract Manufacturing stocks look cheap relative to their growth?

Among Contract Manufacturing stocks, the largest companies growing revenue faster than the median (2.9%) while trading below the median P/E (24.62) are Adma Biologics (ADMA), Amphastar Pharmaceuticals (AMPH), MeiraGTx Holdings (MGTX), Elite Pharmaceuticals (ELTP) and Nortech Systems (NSYS). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Contract Manufacturing stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Pfizer (PFE), Teva Pharmaceutical Industries (TEVA), Charles River Laboratories International (CRL), Dr Reddys Laboratories (RDY) and Ligand Pharmaceuticals (LGND).

What is the median P/E of Contract Manufacturing stocks?

The median P/E across the 22 Contract Manufacturing stocks plotted is 24.62, with the middle half between 14.52 and 39.79.

What is the median Revenue Growth (1y) (TTM) of Contract Manufacturing stocks?

The median is 2.9%, with the middle half between 0.9% and 9.8%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Contract Manufacturing stocks?

The rank correlation (Spearman) is -0.20, a weak negative relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a lower P/E.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 1 companies are outliers on Revenue Growth (1y) (TTM) and 2 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.